BioRestorative Therapies (BRTX) to Release Earnings on Thursday

BioRestorative Therapies (NASDAQ:BRTX) will likely be posting its quarterly earnings results on Thursday, March 27th. Analysts expect BioRestorative Therapies to post earnings of ($0.34) per share and revenue of $0.48 million for the quarter.

BioRestorative Therapies Stock Performance

NASDAQ BRTX opened at $1.97 on Tuesday. The firm has a market capitalization of $13.63 million, a P/E ratio of -1.29 and a beta of 64.37. The stock has a 50-day simple moving average of $1.98 and a two-hundred day simple moving average of $1.72. BioRestorative Therapies has a fifty-two week low of $1.03 and a fifty-two week high of $2.55.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.